National Center for Cancer Immune Therapy of Denmark at ESMO Immuno-Oncology Congress 2024
CCIT-DK – National Center for Cancer Immune Therapy of Denmark shared a post on LinkedIn:
“CCIT-DK – National Center for Cancer Immune Therapy of Denmark at ESMO – European Society for Medical Oncology Immuno-Oncology Congress 2024 (Geneva, 11-13 December 2024).
Strong Presence of Our Team at the Europe’s Leading Immuno-Oncology Oncology Event.
– Inge Marie Svane (CCIT-DK Co-Director): Meeting co-chair, talks.
– Mads Hald Andersen (CCIT-DK Co-Director): Immuno-Modulatory Vaccines (Cancer Vaccines session).
– Marco Donia (CCIT-DK, PI ofTIL Group PI): Impact of Real-World data on Treatment Guidelines (Real-World Benefit of Immunotherapy); Mini-Oral Discussant.
– Mario Presti (PhD Student, TIL group): Immunological dynamics of HLA-II positive melanoma (Mini-Oral).
– Cecilie Dam Vestergaard (PhD Student, IMS Group): Impact of Assessment-to-Treatment Interval on the Predictive Value of PD-L1 Expression in Melanoma.
ESMOImmuno24 Looking forward to ESMOImmuno25 in London.”
Marco Donia, Senior Consultant, Clinician-Scientist and Junior Research Group Leader (TIL group) at the Department of Oncology and Center for Cancer Immune Therapy, University of Copenhagen Herlev Hospital, reshared the post on LinkedIn, adding:
“Thanks to ESMO – European Society for Medical Oncology for the opportunity to chair and present in the session of Real-World Evidence in Cancer Immunotherapy at ESMOImmuno24 (ESMO Immuno Oncology 2024)!
Editorial (Real-world evidence has a place in cancer immunotherapy, ESMO Daily Reporter).
Real-world benefit of immunotherapy: webcasts of the whole session available at (require ESMO registration).
Speakers: Timothée Olivier, Travis Osterman, Marco Donia, Patrick Pauwels.
My slides on “Impact of real-world data on clinical treatment guidelines” freely available.”
Marco Donia is a Senior Consultant, Clinician-Scientist and Junior Research Group Leader (TIL group) at the Department of Oncology and Center for Cancer Immune Therapy, University of Copenhagen Herlev Hospital, Denmark. He serves as an Associate Professor in Clinical Oncology at the University of Copenhagen. Donia is also a clinical oncologist treating patients with cancer immunotherapy. His research group is currently investigating new immune-regulatory circuits in PD-1/PD-L1 resistant tumors.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023